Literature DB >> 21595629

"European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary.

Dimitri P Mikhailidis1, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried März, Klaus G Parhofer, Giovam Battista Rini, Giatgen A Spinas, Gerald H Tomkin, Alexandros D Tselepis, Anthony S Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21595629     DOI： 10.2174/157016111796642698

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN： 1570-1611            Impact factor:   2.719


× No keyword cloud information.
  17 in total

1.  High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.

Authors:  Michael S Kostapanos; Moses S Elisaf
Journal:  World J Exp Med       Date:  2014-02-20

2.  Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study.

Authors:  Peter E Penson; D Leann Long; George Howard; Peter P Toth; Paul Muntner; Virginia J Howard; Monica M Safford; Steven R Jones; Seth S Martin; Mohsen Mazidi; Alberico L Catapano; Maciej Banach
Journal:  Eur Heart J       Date:  2018-10-21       Impact factor: 29.983

3.  The Role of Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio to Predict New Cardiovascular Events in Essential Hypertensive Patients.

Authors:  Osman Turak; Barış Afşar; Fırat Ozcan; Fatih Öksüz; Mehmet Ali Mendi; Çagrı Yayla; Adrian Covic; Nathan Bertelsen; Mehmet Kanbay
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-12-22       Impact factor: 3.738

4.  The effects of statins on blood pressure: current knowledge and future perspectives.

Authors:  Manfredi Rizzo; Giuseppe Montalto; Maciej Banach
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

5.  The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.

Authors:  Alper Sonmez; Mahmut Ilker Yilmaz; Mutlu Saglam; Hilmi Umut Unal; Mahmut Gok; Hakki Cetinkaya; Murat Karaman; Cem Haymana; Tayfun Eyileten; Yusuf Oguz; Abdulgaffar Vural; Manfredi Rizzo; Peter P Toth
Journal:  Lipids Health Dis       Date:  2015-04-16       Impact factor: 3.876

6.  The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome.

Authors:  Stefania Makariou; Evangelos Liberopoulos; Matilda Florentin; Konstantinos Lagos; Irene Gazi; Anna Challa; Moses Elisaf
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

Review 7.  Does inflammation determine whether obesity is metabolically healthy or unhealthy? The aging perspective.

Authors:  Iftikhar Alam; Tze Pin Ng; Anis Larbi
Journal:  Mediators Inflamm       Date:  2012-10-04       Impact factor: 4.711

Review 8.  Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approaches.

Authors:  Dragana Nikolic; Niki Katsiki; Giuseppe Montalto; Esma R Isenovic; Dimitri P Mikhailidis; Manfredi Rizzo
Journal:  Nutrients       Date:  2013-03-18       Impact factor: 5.717

9.  The effect of intensive glucose lowering on lipoprotein particle profiles and inflammatory markers in the Veterans Affairs Diabetes Trial (VADT).

Authors:  Juraj Koska; Aramesh Saremi; Gideon Bahn; Shizuya Yamashita; Peter D Reaven
Journal:  Diabetes Care       Date:  2013-03-27       Impact factor: 19.112

10.  Effects of lipid-lowering drugs on high-density lipoprotein subclasses in healthy men-a randomized trial.

Authors:  Heiner K Berthold; Manfredi Rizzo; Nadine Spenrath; Giuseppe Montalto; Wilhelm Krone; Ioanna Gouni-Berthold
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.